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Peritoneal dialysis: Changes to the structure of the peritoneal approximately 20 years. It has, along with HD, now been
membrane and potential for biocompatible solutions. accepted in many countries as an equivalent form of
Background. Peritoneal dialysis (PD) is now established as therapy [1]. Indeed, there is evidence to suggest thata viable and successful alternative to hemodialysis (HD) for
patients starting on PD survive for up to three yearspatients starting on renal replacement therapy. A number of
longer than their HD counterparts [2]. In addition, it hasstudies have confirmed that equivalent adequacy and fluid bal-
ance are provided at least for the first four to five years of been suggested that patients who started on PD and then
renal replacement therapy (RRT). Loss of peritoneal mem- switched, when required, to HD had a better long-term
brane function remains a major factor leading to treatment outcome than those starting directly on HD [3].failure in a significant number of patients on PD. Numerous
Despite this outcome up to 50% of patients drop outstudies have suggested a relationship between these changes
in function and structural changes in the membrane. A careful of PD within five years of starting therapy [4]. Some of
analysis of peritoneal biopsies from PD patients would allow these dropouts are because of the availability of a kidney
the clear identification of those changes unique to PD, in addi- for transplantation. Others drop out because of repeated
tion to indicating possible correlations with glucose exposure
infections (episodes of peritonitis or tunnel infections)as well as other functional parameters.
or a gradual loss of ultrafiltration. The latter are thoughtMethods. We systematically examined peritoneal biopsies
from 13 normal individuals, 29 uremic predialysis patients, 55 to be due to peritoneal membrane changes.
HD patients, and 157 patients on long-term PD. Well-oriented Although a number of small studies have been carried
specimens were stained with toluidine blue and examined by out over the past decade demonstrating the changes ina blinded pathologist. Limited clinical data has allowed a pre-
the morphology of the membrane in relation either toliminary analysis of structure-function relationships.
time on dialysis [5] or recurrent peritonitis [6], no largeResults. The median thickness of the submesothelial com-
pact collagenous zone was 40 m in normal individuals, 150 scale, systematic study has been available until recently.
m in uremic patients, 150 m in patients on HD, and 2550 The Peritoneal Biopsy Registry was established with
m in patients on PD (P 0.001 for all vs. normal individuals).
the specific aim of systematically collecting peritonealCompact zone thickness increased significantly with duration
biopsies from patients at various times on PD, as wellof PD therapy (0 to 24 months, 180 m; 97 months, 600
m). Vascular changes comprised progressive subendothelial as from patients who were on HD (who never had PD),
hyalinization of postcapillary venules, with luminal narrowing from uremic predialysis patients, and from normal indi-
or obliteration. These changes were present in uremic patients viduals [7]. A pilot study was set up to establish a stan-and increased significantly with PD duration (P  0.0001).
dardized method of collecting samples the avoidance ofConclusions. These data indicate that morphologic changes
fixation artifacts and the means of storing well-orientedin the postcapillary venules and the submesothelial compact
zone of PD patients begin during the uremic phase of their samples for morphologic analysis. In addition, clinical
illness. This is then worsened by time spent on PD. The rela- data was collected from each individual patient so that
tionships with glucose exposure or glucose degradation prod- structure-function relationships could be examined inucts have yet to be established.
order to attempt to explain the reasons behind functional
changes in patients on PD.
Figure 1 shows a normal parietal peritoneal mem-Peritoneal dialysis (PD) has now been a major form
brane. The surface is lined by a continuous sheet of flatof treatment for end stage renal disease (ESRD) for
mesothelial cells, which, under ideal conditions, have
their surface area vastly increased by the presence of
microvilli. The mesothelial cells lie on a discontinuousKey words: peritoneal dialysis, submesothelial compact collagenous
zone, uremia. basement membrane composed almost entirely of Type
IV collagen. The submesothelial compact zone of the 2003 by the International Society of Nephrology
S-158
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Fig. 1. Morphologic features of the parietal peritoneal membrane.
Shown is a well-oriented biopsy from a normal individual. Key features
include the surface mesothelial monolayer, the submesothelial compact
zone, and the capillary plexus.
Fig. 2. Changes in the submesothelial compact zone with biopsy origin
and with PD duration. The thickness of the submesothelial compact
zone (in micrometers) was measured in biopsies from normal individu-
normal membrane consists of bundles of collagen fibers als, uremic patients, patients undergoing HD, and patients undergoing
PD, grouped according to duration of dialysis. Data are presented asloosely arranged and interwoven with occasional elastin
box plots, with the boxes representing the interquartile range (IQR).fibers. Careful examination of specimens shows intermit- Lines extend from the box to the highest and lowest values, excluding
tent macrophages and fibroblasts dispersed throughout outliers. The circles represent outliers.
this compact zone, together with the occasional dendro-
cyte. The vascular bed is maximal at the junction of
the compact zone with the underlying adipose tissue,
MORPHOLOGIC CHANGES SEEN IN THEalthough occasional blood vessels run within the compact
PERITONEAL MEMBRANEzone.
In the biopsies of patients on PD, approximately 51%To date, we have collected 157 samples from patients
had intact mesothelium. Of those with intact mesothe-on PD, 55 samples from patients on HD, 29 samples
lium, 40% of cells in the remaining biopsies had reactivefrom predialysis patients, and 13 samples from normal
changes (i.e., cells appeared hypertrophied with a cuboidindividuals. Samples of the parietal peritoneum were
shape and exhibited loss of surface microvilli). In biop-obtained and fixed in a standardized manner. Pieces were
sies taken from uremic patients or from normal individu-routinely processed for scanning electron microscopy,
als, intact mesothelium was greater than at present infor light microscopy, and for transmission electron mi-
more than 98% of samples.croscopy. Semi-thin sections for light microscopy (0.4
Examination of the submesothelial compact zone
m) were stained with 0.5% toluidine blue for morpho-
identified active inflammation in only 12% of biopsies.
logic assessment and stained by using a modification of Acute inflammation with the presence of polymorphs
the PAS silver protein and silver enhancement method was only seen in 4% of biopsies. None of these samples
to observe small blood vessels and lymphatics. An expe- had reactive changes and active inflammation was ab-
rienced histopathologist, who was unaware of the patient sent.
characteristics and clinical details, assessed samples. The median thickness of the peritoneal membrane in
During assessment of the specimens, attention was normal individuals was 40m with an interquartile range
paid to the morphologic features of the mesothelial sur- of 30 to 70 m (Fig. 2). There was a significant increase
face and the underlying interstitium. The integrity of in the thickness of the submesothelial compact zone in
the mesothelium was assessed and any inflammation or samples from both the uremic patients and HD patients
foreign material was noted. The maximum thickness of who had never been on PD. Median thickness for both
the submesothelial compact zone in m was measured in groups was 150 m (P  0.001, respectively, compared
sections orientated perpendicular to the serosal surface. to normal subjects).
Fibrosis was defined as a submesothelial compact zone The analysis of biopsies from patients on PD showed
a progressive increase in the thickness of the submeso-measuring greater than 150 m.
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thelial compact zone with time on dialysis, progressing
from 180 m (IQR 105 to 325 m) in a group of patients
who have been on PD for less than 24 months, up to
600 m (IQR 400 to 1050 m) in the group that had
undergone PD for more than eight years. These results
confirm those findings of a previous study [8] of biopsies
from a small group of PD patients.
Subanalysis of the biopsies from patients on PD dem-
onstrated that the thickness of the submesothelial com-
pact zone in patients who underwent biopsies during
transplantation or incidental surgery was significantly
less than that seen in patients who underwent catheter-
related surgery or exhibited membrane failure. The me- Fig. 3. Changes in the grade of vasculopathy according to the origin
of the peritoneal biopsy. Grade 1, subendothelial hyaline zone7 m;dian thickness of the transplant group was 180 m, in-
Grade 2, subendothelial hyaline zone 7 m; Grade 3, the lumen iscreasing to 675 m in the membrane failure group.
distorted or narrowed; Grade 4, the vascular lumen is obliterated by
In addition to an increased thickness of the submeso- connective tissue which sometimes contains fine calcific stippling.
thelial compact zone, many of the biopsies exhibited
vascular abnormalities, which were manifest by varying
degrees of subendothelial hyalinization [9]. This predom-
ated the number of vessels per unit length of PD surface,inantly affected postcapillary venules, but occasionally
irrespective of the depth of the membrane. Only in thosearterioles, and as such, appears to be distinct from dia-
patients with membrane failure or with PD-related sur-betic vasculopathy. The hyaline material was PSA-posi-
gery was there an increase in vessel number when com-tive, which on further analysis was shown to be type
pared to normal biopsies.IV collagen. In florid cases, this led to distortion and
The data from our study identifies, for the first time,narrowing of the vascular lumen and, eventually, com-
specific changes in both the morphology of the submeso-plete luminal obliteration. No vasculopathy was ob-
thelial compact zone, as well as in the vascular bed ofserved in biopsies from normal subjects. Among non–PD
the peritoneal membrane of patients on PD. It also estab-patients the overall prevalence of vasculopathy was 28%.
lishes that these changes may begin during the develop-This was similar to that seen in the group of patients that
ment of uremia. Blood vessel changes are peculiar tohad undergone PD for up to 24 months. The presence of
postcapillary venules in the majority of biopsies and seenvasculopathy increased as the duration of PD increased,
only occasionally in smaller arterioles. This process isto a value of around 90% for patients who had been on
distinct from that seen during diabetes, but the athero-PD for more than 72 months.
sclerotic type changes are usually seen in medium-sizedVasculopathy was graded in accordance with the de-
arterioles.gree of subendothelial hyalinization (grade I being less
Preliminary analysis of the clinical data demonstratedthan 7 m in thickness, grade II greater than 7 m, grade
a positive, but weak, correlation between the total num-III luminal distortion or narrowing, grade IV luminal
ber of peritonitis episodes recorded and the thickness ofobliteration). Those patients with membrane failure or
the submesothelial compact zone. The changes in thick-who had undergone PD-related surgery had the greatest
ness of the compact zone and the development of vascu-proportion of vasculopathy, as well as the most severe
lopathy both appear to be related to total glucose expo-vasculopathy. Patients whose biopsies had been taken
sure. These changes appear to be related to total timeat time of transplantation, or from miscellaneous surgery,
on PD rather than glucose concentration factored forhad proportionately less vasculopathy and lower grade
time on dialysis. In addition, there was a weak correlationvasculopathy (Fig. 3). When vasculopathy and fibrosis
between the number of peritonitis episodes and the in-were compared statistically there was a strong correla-
creased thickness of the compact zone.tion between the presence of vasculopathy and the pres-
The accumulation of clinical data, together with peri-ence of fibrosis. This relationship was such that it appears
toneal biopsies, will make a comprehensive analysis ofvasculopathy may well precede fibrosis, but that the
structure-function relationships in PD possible. The ad-cause of fibrosis is multifactorial, and there are other
vent of the newer generation of neutral pH fluids withcauses besides vasculopathy.
alternative buffering agents, and with a significant low-A number of centers have identified changes in blood
ering of the concentrations of glucose degradation prod-vessel number, particularly in patients with membrane
ucts, represents a significant potential for a more biocom-failure [10]. Patients with peritoneal fibrosis were shown
patible milieu within the peritoneal cavity [11, 12]. Theto have an increase in blood vessel numbers, or angiogen-
esis. Using specific staining (patch staining), we enumer- availability of peritoneal biopsies from patients exposed
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